AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
STREPTOZOTOCIN-INDUCED AND ALLOXAN-INDUCED DIABETES MODIFIES TOTAL PLASMA AND LIPOPROTEIN LIPID-CONCENTRATION AND COMPOSITION WITHOUT ALTERING CHOLESTERYL ESTER TRANSFER ACTIVITY
Authors: WASAN KM NG SP WONG W RODRIGUES BB
Citation: Km. Wasan et al., STREPTOZOTOCIN-INDUCED AND ALLOXAN-INDUCED DIABETES MODIFIES TOTAL PLASMA AND LIPOPROTEIN LIPID-CONCENTRATION AND COMPOSITION WITHOUT ALTERING CHOLESTERYL ESTER TRANSFER ACTIVITY, Pharmacology & toxicology, 83(4), 1998, pp. 169-175
PLASMA-LIPOPROTEIN DISTRIBUTION OF LIPOSOMAL NYSTATIN IS INFLUENCED BY PROTEIN-CONTENT OF HIGH-DENSITY-LIPOPROTEINS
Authors: CASSIDY SM STROBEL FW WASAN KM
Citation: Sm. Cassidy et al., PLASMA-LIPOPROTEIN DISTRIBUTION OF LIPOSOMAL NYSTATIN IS INFLUENCED BY PROTEIN-CONTENT OF HIGH-DENSITY-LIPOPROTEINS, Antimicrobial agents and chemotherapy, 42(8), 1998, pp. 1878-1888
DIFFERENCES IN THE LIPOPROTEIN DISTRIBUTION OF FREE AND LIPOSOME-ASSOCIATED ALL-TRANS-RETINOIC ACID IN HUMAN, DOG, AND RAT PLASMA ARE DUE TO VARIATIONS IN LIPOPROTEIN LIPID AND PROTEIN-CONTENT
Authors: WASAN KM RAMASWAMY M NG SP WONG W PARROTT SC OJWANG JO WALLACE T COSSUM PA
Citation: Km. Wasan et al., DIFFERENCES IN THE LIPOPROTEIN DISTRIBUTION OF FREE AND LIPOSOME-ASSOCIATED ALL-TRANS-RETINOIC ACID IN HUMAN, DOG, AND RAT PLASMA ARE DUE TO VARIATIONS IN LIPOPROTEIN LIPID AND PROTEIN-CONTENT, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1646-1653
LIPID TRANSFER PROTEIN-I FACILITATED TRANSFER OF CYCLOSPORINE FROM LOW-TO HIGH-DENSITY-LIPOPROTEINS IS ONLY PARTIALLY DEPENDENT ON ITS CHOLESTERYL ESTER TRANSFER ACTIVITY
Authors: WASAN KM RAMASWAMY M WONG W PRITCHARD PH
Citation: Km. Wasan et al., LIPID TRANSFER PROTEIN-I FACILITATED TRANSFER OF CYCLOSPORINE FROM LOW-TO HIGH-DENSITY-LIPOPROTEINS IS ONLY PARTIALLY DEPENDENT ON ITS CHOLESTERYL ESTER TRANSFER ACTIVITY, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 599-605
ROLE OF PLASMA-LIPOPROTEINS IN MODIFYING THE BIOLOGICAL-ACTIVITY OF HYDROPHOBIC DRUGS
Authors: WASAN KM CASSIDY SM
Citation: Km. Wasan et Sm. Cassidy, ROLE OF PLASMA-LIPOPROTEINS IN MODIFYING THE BIOLOGICAL-ACTIVITY OF HYDROPHOBIC DRUGS, Journal of pharmaceutical sciences, 87(4), 1998, pp. 411-424
ENHANCED AMPHOTERICIN-B NEPHROTOXICITY IN INTENSIVE-CARE PATIENTS WITH ELEVATED LEVELS OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL
Authors: WASAN KM CONKLIN JS
Citation: Km. Wasan et Js. Conklin, ENHANCED AMPHOTERICIN-B NEPHROTOXICITY IN INTENSIVE-CARE PATIENTS WITH ELEVATED LEVELS OF LOW-DENSITY-LIPOPROTEIN CHOLESTEROL, Clinical infectious diseases, 24(1), 1997, pp. 78-80
DIVERSITY OF LIPID-BASED POLYENE FORMULATIONS AND THEIR BEHAVIOR IN BIOLOGICAL-SYSTEMS
Authors: WASAN KM LOPEZBERESTEIN G
Citation: Km. Wasan et G. Lopezberestein, DIVERSITY OF LIPID-BASED POLYENE FORMULATIONS AND THEIR BEHAVIOR IN BIOLOGICAL-SYSTEMS, European journal of clinical microbiology & infectious diseases, 16(1), 1997, pp. 81-92
BLOOD AND PLASMA-LIPOPROTEIN DISTRIBUTION AND GENDER DIFFERENCES IN THE PLASMA PHARMACOKINETICS OF LIPID-ASSOCIATED ANNAMYCIN
Authors: WASAN KM KWONG M
Citation: Km. Wasan et M. Kwong, BLOOD AND PLASMA-LIPOPROTEIN DISTRIBUTION AND GENDER DIFFERENCES IN THE PLASMA PHARMACOKINETICS OF LIPID-ASSOCIATED ANNAMYCIN, Pharmacology & toxicology, 80(6), 1997, pp. 301-307
DIFFERENCES IN LIPOPROTEIN LIPID-CONCENTRATION AND COMPOSITION MODIFYTHE PLASMA DISTRIBUTION OF CYCLOSPORINE
Authors: WASAN KM PRITCHARD PH RAMASWAMY M WONG W DONNACHIE EM BRUNNER LJ
Citation: Km. Wasan et al., DIFFERENCES IN LIPOPROTEIN LIPID-CONCENTRATION AND COMPOSITION MODIFYTHE PLASMA DISTRIBUTION OF CYCLOSPORINE, Pharmaceutical research, 14(11), 1997, pp. 1613-1620
PHYSICAL CHARACTERISTICS AND LIPOPROTEIN DISTRIBUTION OF LIPOSOMAL NYSTATIN IN HUMAN PLASMA
Authors: WASAN KM RAMASWAMY M CASSIDY SM KAZEMI M STROBEL FW THIES RL
Citation: Km. Wasan et al., PHYSICAL CHARACTERISTICS AND LIPOPROTEIN DISTRIBUTION OF LIPOSOMAL NYSTATIN IN HUMAN PLASMA, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1871-1875
MODIFICATIONS IN HIGH-DENSITY-LIPOPROTEIN LIPID-COMPOSITION AND STRUCTURE ALTER THE PLASMA DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN
Authors: WASAN KM NG S CASSIDY SM
Citation: Km. Wasan et al., MODIFICATIONS IN HIGH-DENSITY-LIPOPROTEIN LIPID-COMPOSITION AND STRUCTURE ALTER THE PLASMA DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN, Journal of pharmaceutical sciences, 86(7), 1997, pp. 872-875
ADMINISTRATION OF LONG-TERM TAMOXIFEN THERAPY MODIFIES THE PLASMA LIPOPROTEIN-LIPID CONCENTRATION AND LIPID TRANSFER PROTEIN-I ACTIVITY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER
Authors: WASAN KM RAMASWAMY M HALEY J DUNN BP
Citation: Km. Wasan et al., ADMINISTRATION OF LONG-TERM TAMOXIFEN THERAPY MODIFIES THE PLASMA LIPOPROTEIN-LIPID CONCENTRATION AND LIPID TRANSFER PROTEIN-I ACTIVITY IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER, Journal of pharmaceutical sciences, 86(7), 1997, pp. 876-879
HUMAN PLASMA DISTRIBUTION OF FREE PACLITAXEL AND PACLITAXEL ASSOCIATED WITH DIBLOCK COPOLYMERS
Authors: RAMASWAMY M ZHANG XC BURT HM WASAN KM
Citation: M. Ramaswamy et al., HUMAN PLASMA DISTRIBUTION OF FREE PACLITAXEL AND PACLITAXEL ASSOCIATED WITH DIBLOCK COPOLYMERS, Journal of pharmaceutical sciences, 86(4), 1997, pp. 460-464
CHARACTERISTICS OF LIPID-BASED FORMULATIONS THAT INFLUENCE THEIR BIOLOGICAL BEHAVIOR IN THE PLASMA OF PATIENTS
Authors: WASAN KM LOPEZBERESTEIN G
Citation: Km. Wasan et G. Lopezberestein, CHARACTERISTICS OF LIPID-BASED FORMULATIONS THAT INFLUENCE THEIR BIOLOGICAL BEHAVIOR IN THE PLASMA OF PATIENTS, Clinical infectious diseases, 23(5), 1996, pp. 1126-1138
MODIFICATIONS IN PLASMA-LIPOPROTEIN CONCENTRATION AND LIPID-COMPOSITION REGULATE THE BIOLOGICAL-ACTIVITY OF HYDROPHOBIC DRUGS
Authors: WASAN KM
Citation: Km. Wasan, MODIFICATIONS IN PLASMA-LIPOPROTEIN CONCENTRATION AND LIPID-COMPOSITION REGULATE THE BIOLOGICAL-ACTIVITY OF HYDROPHOBIC DRUGS, Journal of pharmacological and toxicological methods, 36(1), 1996, pp. 1-11
NEPHROPROTECTIVE MECHANISM(S) OF PENTOXIFYLLINE - REDUCTION OF ERYTHROCYTE-MEDIATED VASCULAR CONGESTION AND INHIBITION OF NITRIC-OXIDE RELEASE
Authors: VADIEI K TUCKER SD LOPEZBERESTEIN G WASAN KM
Citation: K. Vadiei et al., NEPHROPROTECTIVE MECHANISM(S) OF PENTOXIFYLLINE - REDUCTION OF ERYTHROCYTE-MEDIATED VASCULAR CONGESTION AND INHIBITION OF NITRIC-OXIDE RELEASE, Pharmacology & toxicology, 78(3), 1996, pp. 174-180
DIFFERENCES IN LIPOPROTEIN CONCENTRATION AND COMPOSITION MODIFY THE PLASMA DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN
Authors: WASAN KM MORTON RE
Citation: Km. Wasan et Re. Morton, DIFFERENCES IN LIPOPROTEIN CONCENTRATION AND COMPOSITION MODIFY THE PLASMA DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN, Pharmaceutical research, 13(3), 1996, pp. 462-468
EVALUATION OF RENAL TOXICITY AND ANTIFUNGAL ACTIVITY OF FREE AND LIPOSOMAL AMPHOTERICIN-B FOLLOWING A SINGLE INTRAVENOUS DOSE TO DIABETIC RATS WITH SYSTEMIC CANDIDIASIS
Authors: WASAN KM CONKLIN JS
Citation: Km. Wasan et Js. Conklin, EVALUATION OF RENAL TOXICITY AND ANTIFUNGAL ACTIVITY OF FREE AND LIPOSOMAL AMPHOTERICIN-B FOLLOWING A SINGLE INTRAVENOUS DOSE TO DIABETIC RATS WITH SYSTEMIC CANDIDIASIS, Antimicrobial agents and chemotherapy, 40(8), 1996, pp. 1806-1810
THE PAST, PRESENT, AND FUTURE USES OF LIPOSOMES IN TREATING INFECTIOUS-DISEASES
Authors: WASAN KM LOPEZBERESTEIN G
Citation: Km. Wasan et G. Lopezberestein, THE PAST, PRESENT, AND FUTURE USES OF LIPOSOMES IN TREATING INFECTIOUS-DISEASES, Immunopharmacology and immunotoxicology, 17(1), 1995, pp. 1-15
DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN WITHIN HUMAN PLASMA IS REGULATED BY PLASMA TRIGLYCERIDE CONCENTRATIONS BUT NOT BY LIPID TRANSFER PROTEIN
Authors: WASAN KM PEREZSOLER R
Citation: Km. Wasan et R. Perezsoler, DISTRIBUTION OF FREE AND LIPOSOMAL ANNAMYCIN WITHIN HUMAN PLASMA IS REGULATED BY PLASMA TRIGLYCERIDE CONCENTRATIONS BUT NOT BY LIPID TRANSFER PROTEIN, Journal of pharmaceutical sciences, 84(9), 1995, pp. 1094-1100
EFFECT OF INTRALIPID INFUSION ON SERUM HIGH-DENSITY AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL, LECITHIN CHOLESTEROL ACYLTRANSFERASE, AND LIPOPROTEIN-LIPASE IN TUMOR-BEARING RATS
Authors: WASAN KM GROSSIE VB
Citation: Km. Wasan et Vb. Grossie, EFFECT OF INTRALIPID INFUSION ON SERUM HIGH-DENSITY AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL, LECITHIN CHOLESTEROL ACYLTRANSFERASE, AND LIPOPROTEIN-LIPASE IN TUMOR-BEARING RATS, Experientia, 51(3), 1995, pp. 230-234
THE INTERACTION OF LIPOSOMAL AMPHOTERICIN-B AND SERUM-LIPOPROTEINS WITHIN THE BIOLOGICAL MILIEU
Authors: WASAN KM LOPEZBERESTEIN G
Citation: Km. Wasan et G. Lopezberestein, THE INTERACTION OF LIPOSOMAL AMPHOTERICIN-B AND SERUM-LIPOPROTEINS WITHIN THE BIOLOGICAL MILIEU, Journal of drug targeting., 2(5), 1994, pp. 373-380
DETERMINATION OF DIMYRISTOYLPHOSPHATIDYLGLYCEROL IN HUMAN SERUM BY LIQUID-LIQUID-EXTRACTION AND REVERSED-PHASE LIQUID-CHROMATOGRAPHY
Authors: WASAN KM HAYMAN AC LOPEZBERESTEIN G
Citation: Km. Wasan et al., DETERMINATION OF DIMYRISTOYLPHOSPHATIDYLGLYCEROL IN HUMAN SERUM BY LIQUID-LIQUID-EXTRACTION AND REVERSED-PHASE LIQUID-CHROMATOGRAPHY, Journal of pharmaceutical and biomedical analysis, 12(6), 1994, pp. 851-854
CONCENTRATIONS IN SERUM AND DISTRIBUTION IN TISSUE OF FREE AND LIPOSOMAL AMPHOTERICIN-B IN RATS DURING CONTINUOUS INTRALIPID INFUSION
Authors: WASAN KM GROSSIE VB LOPEZBERESTEIN G
Citation: Km. Wasan et al., CONCENTRATIONS IN SERUM AND DISTRIBUTION IN TISSUE OF FREE AND LIPOSOMAL AMPHOTERICIN-B IN RATS DURING CONTINUOUS INTRALIPID INFUSION, Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2224-2226
INFLUENCE OF LIPOPROTEINS ON RENAL CYTOTOXICITY AND ANTIFUNGAL ACTIVITY OF AMPHOTERICIN-B (VOL 38, PG 224, 1994)
Authors: WASAN KM ROSENBLUM MG CHEUNG L LOPEZBERESTEIN G
Citation: Km. Wasan et al., INFLUENCE OF LIPOPROTEINS ON RENAL CYTOTOXICITY AND ANTIFUNGAL ACTIVITY OF AMPHOTERICIN-B (VOL 38, PG 224, 1994), Antimicrobial agents and chemotherapy, 38(9), 1994, pp. 2230-2230
Risultati: 1-25 | 26-28